[Endolymphatic curietherapy by lymphography with labelled lipiodol in Hodgkin's disease. A report on 408 cases (author's transl)]. 1979

J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier

The results of 373 lymphography examinations with radioactive lipiodol, conducted in 408 patients with Hodgkin's disease for diagnostic and prophylactic therapeutic purposes, during investigations carried out from 1966 to 1973 are analyzed. Tolerance was always excellent, especially from the hematological point of view. The efficacy of the procedure can be assessed by the fact that there were only 6% of failures (21/373) in glandular regions irradiated in this way for prophylactic purposes. Relapses occur more frequently in the inguino-iliac and lumbo-aortic regions than in the pelvic chains which were perfectly protected. This technique also enables both pelvic irradiation and ovarian protection in young women without any risk of failure. The procedure is particularly indicated in the following cases: supradiaphragmatic stages I and II, whatever the sex, and stage III especially in women. In sub-diaphragmatic stages I and II, it allows, in favourable cases, the ovarian function in women to remain intact by limiting external irradiation to invaded regions only.

UI MeSH Term Description Entries
D007459 Iodized Oil A preparation of oil that contains covalently bound IODINE. It is commonly used as a RADIOCONTRAST AGENT and as a suspension medium for CHEMOTHERAPEUTIC AGENTS. Oil, Iodized,Iodized Oils,Iodolipol,Oils, Iodized
D008220 Lymphography Radiographic study of the lymphatic system following injection of dye or contrast medium. Lymphangiography,Lymphangiographies,Lymphographies
D008297 Male Males
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011835 Radiation Protection Methods and practices adopted to protect against RADIATION. Protection, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma

Related Publications

J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier
January 1966, Nouvelle revue francaise d'hematologie,
J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier
March 1977, Annales de radiologie,
J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier
January 1970, Radiobiologia, radiotherapia,
J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier
February 1980, Haematologica,
J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier
January 1977, Radiologia diagnostica,
J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier
August 1979, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier
December 1976, Radiologia diagnostica,
J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier
January 1977, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier
January 1979, Annales de medecine interne,
J L Chassard, and B Lahnèche, and J Papillon, and L Revol, and P Chauvot, and D Jaussaud, and J F Garnier
April 1977, Bratislavske lekarske listy,
Copied contents to your clipboard!